SourceOne Stock Info  Your one source site for stock research




Company Website

Investor Relations



What’s the buzz—

message boards


Market Watch

Money Central

Raging Bull

Board Central









Cephalon, Inc.



Cephalon, Inc. is an international biopharmaceutical company involved in the research, development and marketing of products to treat human diseases. The Company focuses its efforts in four core therapeutic areas: central nervous system disorders, pain, cancer and addiction. In addition to conducting an active research and development program, the company markets six products in the United States and number of products in countries throughout Europe. The Company’s main product is PROVIGIL (modafinil) Tablets (C-IV), which composed approximately 43% of its total consolidated net sales during the year ended December 2006, of which approximately 94% was in the United States market. Its product, ACTIQ (oral transmucosal fentanyl citrate) (C-II), accounted for about 34% of its total consolidated net sales during 2006, of which approximately 95% was in the United States.


Stock Quotes and Other Information





Silicon Investor



Market Watch

Clear Station



SourceOne Message Board


Search for Stocks:

A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z

Alphabetical Listings by Company Name















S&P 100     S&P 500     S&P 400     Dow Jones Industrials     Dow Jones Transportation     Dow Jones Utilities     Dow Jones Composite     Nasdaq 100     Morgan Stanley Hi-Tech 35